[{"Assets_0_Q2_USD":1336259000.0,"CommonStockSharesOutstanding_0_Q2_shares":54179374.0,"EarningsPerShareBasic_1_Q2_USD":0.06,"EarningsPerShareBasic_2_Q2_USD":0.45,"EarningsPerShareDiluted_1_Q2_USD":0.06,"EarningsPerShareDiluted_2_Q2_USD":0.45,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":98424000.0,"NetIncomeLoss_1_Q2_USD":3389000.0,"NetIncomeLoss_2_Q2_USD":24576000.0,"StockholdersEquity_0_Q2_USD":353438000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":55307000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":55215000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":54123000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":54069000.0,"Ticker":"SYNH","CIK":"1610950","name":"INC RESEARCH HOLDINGS, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170727"}]